These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 15641668)

  • 21. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes.
    Ray JA; Boye KS; Yurgin N; Valentine WJ; Roze S; McKendrick J; Tucker DM; Foos V; Palmer AJ
    Curr Med Res Opin; 2007 Mar; 23(3):609-22. PubMed ID: 17355742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antidiabetic agents and renal insufficiency].
    Robles NR; Blanco J
    Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin therapy and exercise.
    Kourtoglou GI
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S73-7. PubMed ID: 21864755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin.
    Panesar P
    Prof Nurse; 2004 Dec; 20(4):51-2. PubMed ID: 15624624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The market in diabetes.
    Hauber A; Gale EA
    Diabetologia; 2006 Feb; 49(2):247-52. PubMed ID: 16416145
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacotherapies for diabetes management: an update for the practicing clinician.
    Meneghini L; Hirsch IB
    Semin Thorac Cardiovasc Surg; 2006; 18(4):379-89. PubMed ID: 17395035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing glycemic control with insulin glargine.
    Williams JB
    Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M; Orsini-Federici M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive insulin treatment in diabetic children.
    Ludvigsson J; Bolli GB
    Diabetes Nutr Metab; 2001 Oct; 14(5):292-304. PubMed ID: 11806471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antidiabetic therapy in diabetic patients with coronary heart disease].
    Faglia E
    Minerva Med; 2003 Dec; 94(6):387-99. PubMed ID: 14976467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensifying insulin therapy in patients with type 2 diabetes mellitus.
    Hirsch IB
    Am J Med; 2005 May; 118 Suppl 5A():21S-6S. PubMed ID: 15850550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of rapid-acting insulin analogs on overall glycemic control in type 1 and type 2 diabetes mellitus.
    Ristic S; Bates PC
    Diabetes Technol Ther; 2003; 5(1):57-66. PubMed ID: 12725708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why, when and how to initiate insulin therapy in patients with type 2 diabetes.
    Tibaldi J; Rakel RE
    Int J Clin Pract; 2007 Apr; 61(4):633-44. PubMed ID: 17394436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on the long-acting insulin analogue glargine.
    Thisted H; Johnsen SP; Rungby J
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Closer to ideal insulin action: ultra fast acting insulins.
    Cengiz E
    Panminerva Med; 2013 Sep; 55(3):269-75. PubMed ID: 24088800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Insulin therapy].
    Brunetti P
    Minerva Endocrinol; 2001 Jun; 26(2):65-86. PubMed ID: 11479436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Home monitoring of glucose and blood pressure.
    Taylor JR; Campbell KM
    Am Fam Physician; 2007 Jul; 76(2):255-60. PubMed ID: 17695570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.